Baofeng takes $146M control of Yinglite in reverse-merger play
What's the deal? Baofeng Group has agreed to buy a 39.41% stake in Shenzhen-listed Yinglite ChemicalDealroom has a profile for this one. Try Dealroom → from state-owned Yinglite Energy & Chemical, a subsidiary of China Energy InvestmentDealroom has a profile for this one. Try Dealroom →, for at least US$133.9M (≈$146 million). Baofeng is controlled by Dang Yanbao, ranked Ningxia's richest person with US$20.6B on the 2026 Hurun Rich List.
What's the endgame? Alongside the buyout, Yinglite plans to issue shares to acquire 100% of Baofeng Solar, folding Dang's solar power business into the listed company. Yinglite makes PVC and caustic soda; its new controlling owner would gain a second A-share listing to house solar assets.
Why now? Dang's new-energy unit, Baofeng New Energy, has spent more than five years in IPO coaching without a listing — it remained on Gansu regulators' guidance list as of late September. A reverse-merger route now offers faster access to public markets.
What's in it for the seller? China Energy Investment has long wanted out of Yinglite, which has posted repeated losses. It lost US$76.2M in 2025 and US$58.4M in the first three quarters of this year, a 71.76% wider loss year on year. An earlier 2016 attempt to sell the business collapsed in 2018.
Why it suits both sides: The deal lets the central state-owned group shed a non-core, loss-making asset, in line with pressure to divest weak units. For Dang, whose Baofeng Group reported US$6.94B in 2025 revenue — up more than 60% over two years — it adds a listing and a platform for solar.
What could go wrong? The solar sector is in a deep downturn, with volatile power prices and consumption pressure weighing on plant earnings. Whether the injected assets prove profitable enough to win over A-share investors remains unclear.
The signal: The transaction shows China's state firms accelerating exits from non-core businesses while private tycoons seize the openings to expand their listed portfolios. For Dang, a buyout plus asset injection sidesteps a stalled IPO — a route more Chinese founders may follow as traditional listings drag on.
Read more: sohu.com
Image credit: Generated with Gemini